Emv Capital (EMVC)

Sector:

Financials

Index:

FTSE AIM All-Share

 49.00p
   
  • Change Today:
      0.000p
  • 52 Week High: 71.00p
  • 52 Week Low: 36.50p
  • Currency: UK Pounds
  • Shares Issued: 27.77m
  • Volume: 14,082
  • Market Cap: £13.61m
  • Beta: 0.00

NetScientific subsidiary Wanda improve patient assistance software

By Duncan Ferris

Date: Wednesday 18 Jul 2018

LONDON (ShareCast) - (Sharecast News) - Healthcare IP commercialisation firm NetScientific on Wednesday announced that portfolio company Wanda has completed a major enhancement of its patient management platform.
Wanda, in which AIM traded firm NetScientific holds a 62% stake on a fully diluted basis, has an existing platform which has been shown to predict 90% of patient-level adverse events up to seven days in advance of their occurrence, according to NetScientific.

The new system includes personalised reminders and alerts, which can be pre-scheduled and delivered to patients via multi-modal communications, and a cloud text-to-speech application programming interface from Google that uses machine learning to deliver natural-sounding human voice automation.

A company statement said the changes provide a "highly intelligent method" to avoid the costs of unplanned readmissions and emergency department visits due to nonadherence.

Francois Martelet, NetScientific's chief executive and chairman of Wanda, said: "Wanda's enhancements to its core technology mean that relationships between clinicians and patients will continue to improve, and will empower patients to take a more active role in the management of their diseases as well as increase their quality of life."

NetScientific's shares were down 1.33% at 38.00p at 1435 BST.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Emv Capital Market Data

Currency UK Pounds
Share Price 49.00p
Change Today 0.000p
% Change 0.00 %
52 Week High 71.00p
52 Week Low 36.50p
Volume 14,082
Shares Issued 27.77m
Market Cap £13.61m
Beta 0.00

Emv Capital Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
11.62% above the market average11.62% above the market average11.62% above the market average11.62% above the market average11.62% above the market average
2% below the sector average2% below the sector average2% below the sector average2% below the sector average2% below the sector average
Price Trend
56.02% below the market average56.02% below the market average56.02% below the market average56.02% below the market average56.02% below the market average
63.11% below the sector average63.11% below the sector average63.11% below the sector average63.11% below the sector average63.11% below the sector average
Income Not Available
Growth
12.02% above the market average12.02% above the market average12.02% above the market average12.02% above the market average12.02% above the market average
16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average16.13% above the sector average

Emv Capital Dividends

No dividends found

Trades for 17-Jul-2025

Time Volume / Share Price
12:28 3,492 @ 47.71p
10:57 1,950 @ 50.40p
08:57 8,000 @ 47.64p
08:51 40 @ 51.00p
08:39 600 @ 50.00p

Emv Capital Key Personnel

CEO Ilian Iliev
CFO Stephen Crowe

Top of Page